secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACCENDRA HEALTH INC/VA/ (ACH)
CIK:        0000075252
Form:       8-K
Filed at:   2023-12-06T23:59:59+00:00
Accession:  0001558370-23-019490
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Owens & Minor sets 2028 targets: revenue >$12B, adj. EPS >$3.50, 20%+ CAGR
--------------------------------------------------------------------------

- 2028 revenue target exceeding $12 billion; adjusted EBITDA above $750 million.
- Adjusted EPS target >$3.50, representing a CAGR of more than 20% from 2024 to 2028.
- Cumulative free cash flow between 2024-2028 expected to exceed $1.3 billion.
- Patient Direct segment expected to outpace the market and strengthen home-based care position.
- Plan includes margin optimization in Products & Healthcare Services and disciplined capital allocation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/75252/000155837023019490/0001558370-23-019490-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/75252/000155837023019490/tmb-20231206x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-019490

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer